@article{06dfe573f7e94761ab1fe57e432cddac,
title = "Hepatitis B Virus-associated Liver Failure in a Patient With B-cell Non-Hodgkin Lymphoma After Anti-cancer Therapy Including Ibrutinib",
keywords = "Hepatitis B virus, Hodgkin lymphoma, Ibrutinib, Liver failure, Reactivation",
author = "Malek, {Alexandre E.} and Yago Nieto and Szvalb, {Ariel D.} and Shaheer Siddiqui and Shafi, {Mehnaz A.} and Hwang, {Jessica P.} and Raad, {Issam I.} and Torres, {Harrys A.}",
note = "Funding Information: Dr Torres is or has been the principal investigator for research grants from Gilead Sciences and Merck & Co, Inc , with all funds paid to MD Anderson . He also is or has been a paid scientific advisor for AbbVie, Inc, Gilead Sciences, Merck & Co, Inc, and Dynavax Technologies. The terms of these arrangements are managed by MD Anderson in accordance with its conflicts of interest policies. Dr Hwang has received research funding from Merck & Co, Inc and Gilead Sciences . The remaining authors have stated that they have no conflicts of interest. Funding Information: Dr Torres is or has been the principal investigator for research grants from Gilead Sciences and Merck & Co, Inc, with all funds paid to MD Anderson. He also is or has been a paid scientific advisor for AbbVie, Inc, Gilead Sciences, Merck & Co, Inc, and Dynavax Technologies. The terms of these arrangements are managed by MD Anderson in accordance with its conflicts of interest policies. Dr Hwang has received research funding from Merck & Co, Inc and Gilead Sciences. The remaining authors have stated that they have no conflicts of interest.",
year = "2020",
month = mar,
doi = "10.1016/j.clml.2019.12.006",
language = "English (US)",
volume = "20",
pages = "e124--e127",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "3",
}